Key result
The Paci2018 in silico model successfully simulated human induced pluripotent stem cell-derived cardiomyocyte action potentials and calcium transients, including delayed afterdepolarizations that previous models could not predict.
Why the study?
Does the updated Paci2018 in silico model better recapitulate Ca2+ handling abnormalities compared to the Paci2013 model in hiPSC-CMs?
Does the updated Paci2018 in silico model better recapitulate Ca2+ handling abnormalities compared to the Paci2013 model in hiPSC-CMs?
The updated Paci2018 in silico model of hiPSC-CMs accurately reproduces calcium transients and delayed afterdepolarizations, providing a versatile platform for modeling drug effects and mutations.
Answers are grounded in this paper and cite their sources.
New hiPSC-CM model may refine Ca2+ simulations for cardiotoxicity testing; leaves open experimental validation before broader use.
The growing importance of human induced pluripotent stem cell-derived cardiomyoyctes (hiPSC-CMs), as patient-specific and disease-specific models for studying cellular cardiac electrophysiology or for preliminary cardiotoxicity tests, generated better understanding of hiPSC-CM biophysical mechanisms and great amount of action potential and calcium transient data. In this paper, we propose a new hiPSC-CM in silico model, with particular attention to Ca2+ handling. We used i) the hiPSC-CM Paci2013 model as starting point, ii) a new dataset of Ca2+ transient measurements to tune the parameters of the inward and outward Ca2+ fluxes of sarcoplasmic reticulum and iii) an automatic parameter optimization to fit action potentials and Ca2+ transients. The Paci2018 model simulates, together with the typical hiPSC-CM spontaneous action potentials, more refined Ca2+ transients and delayed afterdepolarizations-like abnormalities, which the old Paci2013 was not able to predict due to its mathematical formulation. The Paci2018 model was validated against i) the same current blocking experiments used to validate the Paci2013 model, and ii) recently published data about effects of different extracellular ionic concentrations. In conclusion, we present a new and more versatile in silico model, which will provide a platform for modeling the effects of drugs or mutations that affect Ca2+ handling in hiPSC-CMs.
No takes yet. Share an insight, caveat, or question.
Paci et al. (2018) studied In silico modeling of human induced pluripotent stem cell-derived cardiomyocytes (n=15). Paci2018 in silico model vs. Paci2013 model was evaluated on Simulation of action potentials and Ca2+ transients. The Paci2018 in silico model successfully simulated human induced pluripotent stem cell-derived cardiomyocyte action potentials and calcium transients, including delayed afterdepolarizations that previous models could not predict.
Synapse has enriched 10 related papers. Consider them for comparative context: